Unresectable melanoma is a melanoma that cannot be removed or resected by surgery. The survival rate for melanoma is high if it is detected early but the advanced form, metastatic melanoma, is an aggressive disease which, until recently, was characterized by high mortality. About Bristol-Myers Squibb Canada Bristol- Myers Squibb Canada is an indirect wholly-owned subsidiary of Bristol-Myers Squibb Company, a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information, please visit www.bmscanada.ca. YERVOY is a registered trademark of Bristol-Myers Squibb Company. SOURCE: Bristol-Myers Squibb Canada Monica Flores, Senior Manager, Public Affairs, Bristol-Myers Squibb Canada, 514-333-3845,